Compare Mounjaro vs Wegovy: Which Weight Loss Treatment Fits You?
Understanding the Difference Between Mounjaro and Wegovy Mechanisms
The fundamental difference between Mounjaro and Wegovy lies in their biological mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural fullness hormone GLP-1, helping reduce appetite and promote satiety after smaller meals. Mounjaro, containing tirzepatide, works as a dual agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously. This dual mechanism may influence how each medication affects appetite regulation, though both are designed to support weight management alongside a reduced-calorie diet and increased physical activity.
Both medications work on brain appetite centres to help reduce food cravings and promote feelings of fullness. The difference between Mounjaro and Wegovy in terms of mechanism doesn't necessarily mean one is superior to the other - rather, individual patients may respond differently to each approach. Your prescriber at EverydayMeds can help evaluate which mechanism might be more suitable based on your medical history, current health status, and weight management goals during your clinical assessment.
Wegovy Pricing and Value for Prescription Weight Loss Treatment
Understanding the cost difference between Mounjaro and Wegovy helps inform your treatment decision at EverydayMeds. Wegovy pricing starts at £79.99 for the 0.25mg starter dose with new customer discount code FIRST40 applied at checkout, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our convenient bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99, providing your first two months of treatment in one order. Returning customers benefit from discount code DOSE25, ensuring continued value throughout their weight management journey.
The pricing structure reflects Wegovy's dose escalation protocol, where patients gradually increase from the starter dose to maintenance level over 16 weeks. Our bundles offer convenience rather than just savings - fewer orders, Reliable Supply continuity, and single delivery arrangements. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring consistent treatment without supply interruptions. This pricing transparency helps patients budget effectively for their long-term weight management commitment, as clinical evidence suggests sustained treatment provides optimal results.
Clinical Evidence: Wegovy vs Mounjaro Weight Loss Research
The difference between Mounjaro and Wegovy becomes evident when examining their respective clinical trial programmes, though direct head-to-head comparisons aren't available due to different study designs and patient populations. Wegovy's STEP trial programme demonstrated that patients may achieve approximately 15% average weight loss at 68 weeks when combined with diet and exercise, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management.
Mounjaro's SURMOUNT trials investigated tirzepatide for weight management, showing different efficacy profiles across various doses and patient groups. However, comparing these results directly would be misleading given the different trial methodologies, endpoints, and participant characteristics. Both medications require prescription-only medicine status and ongoing medical supervision, emphasising that individual response may vary significantly regardless of average trial outcomes reported in clinical studies.
How Wegovy Works for Prescription Weight Loss Management
Wegovy functions as a GLP-1 receptor agonist, essentially mimicking a natural hormone your body produces when you eat to signal fullness and satisfaction. Once injected weekly using the convenient FlexTouch pen system, semaglutide travels through your bloodstream to appetite control centres in your brain, helping reduce the urge to eat and promoting earlier satiety during meals. This mechanism may help patients feel satisfied with smaller portions and experience fewer food cravings between meals, supporting adherence to reduced-calorie eating patterns. The medication works most effectively when combined with lifestyle modifications including dietary changes and increased physical activity, as outlined in the UK licensing requirements. Understanding this mechanism helps explain why Wegovy represents a medical approach to weight management rather than a standalone solution, requiring commitment to comprehensive lifestyle changes for optimal results.
Ordering Process: Getting Started with Wegovy at EverydayMeds
Beginning your Wegovy prescription weight loss journey involves completing our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for treatment and identify any potential contraindications or drug interactions. Our GPhC-registered prescribers (#9012878) review every assessment within 3 working days (or 24 hours with express service), ensuring thorough medical evaluation before approving treatment. Once approved, your Wegovy arrives via next-day delivery using our temperature-controlled cold-chain system, maintaining medication integrity from our pharmacy to your door. The assessment covers your medical history, current medications, weight management goals, and previous treatment experiences, providing prescribers with comprehensive information to make informed treatment decisions. This rigorous process ensures patient safety whilst maintaining convenient access to prescription weight loss treatment through our established online pharmacy platform.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
A practical difference between Mounjaro and Wegovy lies in their storage requirements and stability profiles, particularly relevant for patients who travel frequently or prefer flexible medication management. Wegovy remains stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature stability period. Both medications require initial refrigerated storage at 2-8°C before first use, and both utilise pre-filled pen injection systems for weekly administration. The Wegovy FlexTouch pen system provides dose accuracy and ease of use, with clear dosing windows and audible click confirmation when injection is complete. Dose escalation follows a mandatory schedule starting at 0.25mg weekly, progressing through 0.5mg, 1mg, and 1.7mg to reach the 2.4mg maintenance dose, with each escalation typically lasting 4 weeks to minimise potential side effects.
Choosing Between Mounjaro and Wegovy: Personalised Treatment Approach
The decision between Mounjaro and Wegovy for prescription weight loss should always be individualised based on your specific medical profile, treatment history, and personal preferences rather than general population statistics. Some patients may respond better to Wegovy's single GLP-1 pathway targeting, whilst others might benefit from Mounjaro's dual receptor approach, though predicting individual response remains challenging without trial experience. Factors influencing treatment choice include existing medical conditions, current medications, previous weight loss attempts, injection preferences, storage requirements, and cost considerations.
Your EverydayMeds prescriber considers these multiple factors during clinical assessment, potentially recommending one treatment initially whilst keeping the other as a future option if needed. Both medications are available through our platform, ensuring continuity of care regardless of which treatment proves most effective for your individual circumstances. The difference between Mounjaro and Wegovy may become more apparent through personal experience rather than theoretical comparison, emphasising the importance of professional medical guidance throughout your weight management journey.
Start Your Prescription Weight Loss Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds with complete prescriber support to help determine which treatment aligns with your weight management goals and medical needs. Our streamlined ordering process combines clinical rigour with convenience, utilising discount codes FIRST40 for new customers and DOSE25 for returning patients to ensure competitive pricing throughout your treatment journey. Begin with our 3-minute clinical assessment to explore whether prescription weight loss treatment is appropriate for your situation, backed by our GPhC-registered pharmacy credentials (#9012878) and commitment to patient safety. The difference between Mounjaro and Wegovy becomes clearer through professional consultation rather than online research alone, ensuring your treatment choice is based on comprehensive medical evaluation. Take the first step towards medically-supervised weight management by completing your assessment today, with next-day delivery available once treatment is approved and both prescription-only medicines subject to ongoing clinical monitoring for optimal outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
